Several hypoxia-related genes have been identified as robust biomarkers in predicting overall survival (OS) of patients with cervical cancer, such as hypoxia-inducible factor-1 alpha (HIF-1α) [14–16]. The gene discussed is HIF1A; the disease is cervical carcinoma.